Are you Dr. Ross?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 78 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
44 Binney Street
D1230
Boston, MA 02115Phone+1 617-632-3237
Summary
- Dr. Robert Ross, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and is a Clinical Instructor in Medicine at Dana-Farber Cancer Institute.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2005
- University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1999
Certifications & Licensure
- MA State Medical License 2003 - 2022
Clinical Trials
- Dose Escalation of IPI-493 in Hematologic Malignancies Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 425 citationsGene Therapy in Patients with Transfusion-Dependent β-ThalassemiaAlexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski, John E.J. Rasko, Jean-Antoine Ribeil
The New England Journal of Medicine. 2018-04-18 - 31 citationsA Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local...Rana R. McKay, Amado J. Zurita, Lillian Werner, Justine Yang Bruce, Michael A. Carducci
Journal of Clinical Oncology. 2016-09-27 - 28 citationsA Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate CancerKevin D. Courtney, Judith Manola, Aymen Elfiky, Robert S. Ross, William Oh
Clinical Genitourinary Cancer. 2015-04-01
Press Mentions
- Chutes & Ladders—After Verastem Pit Stop, Bluebird Vet Neumann Lands at KiteFebruary 12th, 2021
- Surface Oncology to Present at the 40th Annual Cowen Healthcare ConferenceFebruary 25th, 2020
- Clasp Emerges with $150M Series a Financing to Advance T Cell EngagersMarch 21st, 2024
- Join now to see all
Professional Memberships
- Member